4.63
price down icon6.19%   -0.3057
after-market Handel nachbörslich: 4.65 0.02 +0.43%
loading

Applied Dna Sciences Inc Aktie (APDN) Neueste Nachrichten

pulisher
Jun 18, 2025

Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward - The Tennessean

Jun 18, 2025
pulisher
Jun 18, 2025

Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward | APDN Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 17, 2025

Applied DNA Sciences names Judy Murrah as new chairperson and CEO - Investing.com India

Jun 17, 2025
pulisher
Jun 17, 2025

Applied DNA Sciences names Judy Murrah as new chairperson and CEO By Investing.com - Investing.com South Africa

Jun 17, 2025
pulisher
Jun 17, 2025

APDN Leadership Transition: Judy Murrah Appointed CEO | APDN Sto - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Applied DNA Sciences Appoints Harvard MBA Veteran Judy Murrah as CEO, Founder Retires After Two Decades - Stock Titan

Jun 17, 2025
pulisher
Jun 16, 2025

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August - Knoxville News Sentinel

Jun 16, 2025
pulisher
Jun 16, 2025

Applied DNA Sciences (APDN) to Restart Quarterly Investor Calls | APDN Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August | APDN Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Applied DNA Sciences Returns to Regular Earnings Updates: What Investors Should Know About New Schedule - Stock Titan

Jun 16, 2025
pulisher
Jun 12, 2025

Applied DNA Reports Second Quarter Fiscal 2025 Financial Results - Knoxville News Sentinel

Jun 12, 2025
pulisher
Jun 10, 2025

Applied DNA Sciences, Inc. (NASDAQ:APDN) Q3 2024 Earnings Call Transcript - MSN

Jun 10, 2025
pulisher
Jun 08, 2025

Applied DNA Sciences fails to secure shareholder vote - MSN

Jun 08, 2025
pulisher
Jun 06, 2025

applied dna sciences faces nasdaq delisting due to bid price rule - Investing.com

Jun 06, 2025
pulisher
Jun 06, 2025

Applied DNA Sciences Faces Nasdaq Delisting Hearing - TipRanks

Jun 06, 2025
pulisher
Jun 06, 2025

Top Premarket Gainers - MarketScreener

Jun 06, 2025
pulisher
Jun 05, 2025

Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17 - Livingston Daily

Jun 05, 2025
pulisher
Jun 05, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Jun 05, 2025
pulisher
Jun 03, 2025

Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025 - Knoxville News Sentinel

Jun 03, 2025
pulisher
Jun 02, 2025

Upcoming Stock Splits This Week (June 2 to June 6) – Stay Invested - The Globe and Mail

Jun 02, 2025
pulisher
May 31, 2025

Applied DNA Sciences, Inc. (NASDAQ:APDN) Short Interest Update - Defense World

May 31, 2025
pulisher
May 31, 2025

APDN stock plunges to 52-week low of $0.32 amid market challenges By Investing.com - Investing.com South Africa

May 31, 2025
pulisher
May 30, 2025

APDN Trading Halted as Market Awaits Significant Announcement | APDN Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

APDN stock plunges to 52-week low of $0.32 amid market challenges - Investing.com Nigeria

May 30, 2025
pulisher
May 30, 2025

Applied DNA announces 1-for-15 reverse stock split - MSN

May 30, 2025
pulisher
May 29, 2025

Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17 | APDN Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Applied DNA Sets Reverse Stock Split for June 2, Moves Key Investor Call to June 17 - Stock Titan

May 29, 2025
pulisher
May 29, 2025

Applied DNA Sciences (APDN) to Implement 1-for-15 Reverse Stock - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Applied DNA Sciences Approves Reverse Stock Split - TipRanks

May 29, 2025
pulisher
May 29, 2025

Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025 | APDN Stock News - GuruFocus

May 29, 2025
diagnostics_research DGX
$176.92
price up icon 0.18%
diagnostics_research WAT
$350.22
price down icon 0.48%
diagnostics_research LH
$261.89
price up icon 0.73%
$161.76
price up icon 0.12%
diagnostics_research MTD
$1,209.08
price up icon 0.28%
diagnostics_research IQV
$164.24
price down icon 0.25%
Kapitalisierung:     |  Volumen (24h):